Transparency data

Non-tech summaries 2016: projects on endocrine disorders

Projects granted during 2016 that have a primary purpose of translational applied research - human endocrine and metabolism disorders.

From:
Home Office
Published
21 December 2017

Documents

Non-technical summaries: projects granted in 2016, volume 26

PDF, 334 KB, 46 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email alternativeformats@homeoffice.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This document outlines the projects granted under the Animals (Scientific Procedures) Act 1986 during 2016 with a primary purpose of translational applied research - human endocrine and metabolism disorders.

The following projects were granted:

  • CNS regulation of energy homeostasis (obesity, inflammation, food-intake, body-weight, glia)

  • mitochondrial function in metabolic diseases (metabolism, heart, mitochondria, diabetes, obesity)

  • novel therapeutics for obesity and metabolic disorders (obesity, metabolic disorders, novel therapeutics)

  • the Rho-GTPase signalling network in health and disease (Rac-GEFs, small GTPases, signalling, inflammation, metabolism)

  • effects on metabolism and endocrine pharmacology (metabolism, endocrine, safety, efficacy, pharmacology)

  • understanding metabolic phenotypes in mouse lines (obesity, insulin, diabetes, mouse, genetics)

  • identifying diabetes, obesity and metabolic disease therapeutics

  • models for endocrine neoplasia (pituitary, parathyroid, pancreatic islets, MEN1, NETs)

  • metabolic dysfunction and degeneration (obesity, diabetes, vascular disease, alzheimer’s)

  • metabolism and toxicity in non-human primates (pharmaceutical, regulatory, primate)

  • cell therapy for diabetes (type 1 diabetes, regenerative medicine, islet transplantation, reprogramming, transdifferentiation)

  • mechanisms regulating obesity, growth and dementia (satiety, growth, alzheimer’s disease, dementia)

  • regulation of glucose homeostasis in vivo (diabetes, islets of Langerhans, insulin secretion, insulin action)

Updates to this page

Published 21 December 2017

Sign up for emails or print this page

Related content